EcoDrugPlus

Cyclin Dependent Kinase 4

Ensembl ID : ENSFHEG00000008283
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSFHEG00000012060
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSFHEG00000012969
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSFHEG00000005815
Gene Symbol: CDK7
3 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSFHEG00000004199
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSFHEG00000015294
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSFHEG00000006181
Gene Symbol: CDA
3 Cross references
199 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSFHEG00000004938
Gene Symbol: LOC105924070
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSFHEG00000013261
Gene Symbol: LOC105940037
3 Cross references
494 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSFHEG00000006976
Gene Symbol: LOC105937200
2 Cross references
553 Possible Orthologues:

Cytochrome P450 3a56

Ensembl ID : ENSFHEG00000013157
Gene Symbol: LOC105940029
3 Cross references
573 Possible Orthologues:

Cytochrome P450 3a56-Like

Ensembl ID : ENSFHEG00000006955
Gene Symbol: LOC105937199
2 Cross references
553 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).